Column GROUP L P, Director, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 324,161 shares at $11.62 ($3.7M) on 2022-05-12, disclosed to the SEC on 2022-05-13.
Open-market purchase of $3.7M NGM by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.23 | 2,657 | $30K | 0.8% |
| 2 | $11.23 | 77,866 | $874K | 23.6% |
| 3 | $11.23 | 77,866 | $874K | 23.6% |
| 4 | $11.85 | 88 | $1K | 0.0% |
| 5 | $11.85 | 2,564 | $30K | 0.8% |
| 6 | $11.62 | 79,945 |
| $929K |
| 25.1% |
| 7 | $11.62 | 2,728 | $32K | 0.9% |
| 8 | $11.62 | 79,945 | $929K | 25.1% |
| 9 | $11.81 | 485 | $6K | 0.2% |
| 10 | $11.81 | 17 | $201 | 0.0% |
| Total | $11.43 avg | 324,161 | $3.7M | 100% |
| Filing → |
| NGM | BUY | 2023-01-12 | $2.0M | — | Filing → |
| NGM | BUY | 2022-11-07 | $1.4M | — | Filing → |
| NGM | BUY | 2022-10-31 | $747K | — | Filing → |